Clinical Trials Browser

Phase 2 × Medulloblastoma × pegfilgrastim × Clear all

NCT05535166 2026-02-12

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Phase 2 Recruiting

Brain Neoplasms, Medulloblastoma